Malignant Neoplasm Clinical Trials in Santiago, Region M. de Santiago
4 recruitingSantiago, Region M. de Santiago, Chile
Showing 1–4 of 4 trials
Recruiting
Phase 2
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Malignant Neoplasm
Merck Sharp & Dohme LLC130 enrolled28 locationsNCT07252739
Recruiting
Phase 1
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Malignant Neoplasm
Merck Sharp & Dohme LLC250 enrolled19 locationsNCT07247110
Recruiting
Phase 2
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Malignant Neoplasm
Merck Sharp & Dohme LLC250 enrolled55 locationsNCT06979596
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Advanced Solid TumorsMalignant Neoplasm
Merck Sharp & Dohme LLC270 enrolled45 locationsNCT06818643